Article metrics

Download PDFPDF

Original research
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced

 

Online download statistics by month:

Online download statistics by month: to

AbstractFullPdf
Total000